Supplemental Guarantor and Non-Guarantor Financial Information (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013		Sep. 30, 2012
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	$ 410,492	$ 424,444	$ 1,240,507		$ 1,287,787
Cost of services sold	220,478	223,889	660,998		679,487
Gross profit	190,014	200,555	579,509		608,300
Selling, general and administrative expenses	(160,820)	(161,207)	(482,634)		(498,842)
Goodwill, intangibles and other long-lived asset impairment	0	(19,132)	(224,320)	[1]	(19,132)
Gain on sale of businesses	0	0	0		5,447
Interest expense and other, net	(22,342)	(22,894)	(66,783)		(67,051)	[2]
Equity in earnings (loss) of subsidiaries	0	0	0		0
Income (loss) before income taxes and equity in net earnings of CareCentrix	6,852	(2,678)	(194,228)		28,722
Income tax (expense) benefit	(3,044)	1,297	(2,457)		(10,878)
Equity in net earnings of CareCentrix	0	1,006	0		1,006
Net income (loss)	3,808	(375)	(196,685)		18,850
Less: Net income attributable to noncontrolling interests	(88)	(148)	(425)		(624)
Net income (loss) attributable to Gentiva shareholders	3,720	(523)	(197,110)		18,226
Comprehensive income (loss)	3,808	(375)	(196,685)		18,850
Gentiva Health Services, Inc. [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	0	0	0		0
Cost of services sold	0	0	0		0
Gross profit	0	0	0		0
Selling, general and administrative expenses	0	0	0		0
Goodwill, intangibles and other long-lived asset impairment		0	0		0
Gain on sale of businesses					0
Interest expense and other, net	(22,355)	(22,917)	(66,829)		(67,138)
Equity in earnings (loss) of subsidiaries	16,144	12,563	(156,813)		50,166
Income (loss) before income taxes and equity in net earnings of CareCentrix	(6,211)	(10,354)	(223,642)		(16,972)
Income tax (expense) benefit	9,931	9,831	26,532		35,198
Equity in net earnings of CareCentrix		0			0
Net income (loss)	3,720	(523)	(197,110)		18,226
Less: Net income attributable to noncontrolling interests	0	0	0		0
Net income (loss) attributable to Gentiva shareholders	3,720	(523)	(197,110)		18,226
Comprehensive income (loss)	3,720	(523)	(197,110)		18,226
Guarantor Subsidiaries [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	398,047	412,963	1,203,258		1,253,781
Cost of services sold	212,543	217,767	638,418		661,151
Gross profit	185,504	195,196	564,840		592,630
Selling, general and administrative expenses	(155,861)	(156,771)	(468,270)		(486,285)
Goodwill, intangibles and other long-lived asset impairment		(19,132)	(224,320)		(19,132)
Gain on sale of businesses					5,449
Interest expense and other, net	0	0	0		0
Equity in earnings (loss) of subsidiaries	(459)	243	(7)		1,260
Income (loss) before income taxes and equity in net earnings of CareCentrix	29,184	19,536	(127,757)		93,922
Income tax (expense) benefit	(13,040)	(7,979)	(29,056)		(44,762)
Equity in net earnings of CareCentrix		1,006			1,006
Net income (loss)	16,144	12,563	(156,813)		50,166
Less: Net income attributable to noncontrolling interests	0	0	0		0
Net income (loss) attributable to Gentiva shareholders	16,144	12,563	(156,813)		50,166
Comprehensive income (loss)	16,144	12,563	(156,813)		50,166
Non-Guarantor Subsidiaries [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	16,429	14,186	48,498		42,429
Cost of services sold	11,919	8,827	33,829		26,759
Gross profit	4,510	5,359	14,669		15,670
Selling, general and administrative expenses	(4,959)	(4,436)	(14,364)		(12,557)
Goodwill, intangibles and other long-lived asset impairment		0	0		0
Gain on sale of businesses					(2)
Interest expense and other, net	13	23	46		87
Equity in earnings (loss) of subsidiaries	0	0	0		0
Income (loss) before income taxes and equity in net earnings of CareCentrix	(436)	946	351		3,198
Income tax (expense) benefit	65	(555)	67		(1,314)
Equity in net earnings of CareCentrix		0			0
Net income (loss)	(371)	391	418		1,884
Less: Net income attributable to noncontrolling interests	(88)	(148)	(425)		(624)
Net income (loss) attributable to Gentiva shareholders	(459)	243	(7)		1,260
Comprehensive income (loss)	(371)	391	418		1,884
Eliminations [Member]
Condensed Consolidating Statement of Comprehensive Income
Total net revenues	(3,984)	(2,705)	(11,249)		(8,423)
Cost of services sold	(3,984)	(2,705)	(11,249)		(8,423)
Gross profit	0	0	0		0
Selling, general and administrative expenses	0	0	0		0
Goodwill, intangibles and other long-lived asset impairment		0	0		0
Gain on sale of businesses					0
Interest expense and other, net	0	0	0		0
Equity in earnings (loss) of subsidiaries	(15,685)	(12,806)	156,820		(51,426)
Income (loss) before income taxes and equity in net earnings of CareCentrix	(15,685)	(12,806)	156,820		(51,426)
Income tax (expense) benefit	0	0	0		0
Equity in net earnings of CareCentrix		0			0
Net income (loss)	(15,685)	(12,806)	156,820		(51,426)
Less: Net income attributable to noncontrolling interests	0	0	0		0
Net income (loss) attributable to Gentiva shareholders	(15,685)	(12,806)	156,820		(51,426)
Comprehensive income (loss)	$ (15,685)	$ (12,806)	$ 156,820		$ (51,426)

[1] (2)At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million. As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million. See Note 9.In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.Hospice and corporate assets were reduced by $220.8 million and $3.5 million, respectively, as a result of the impairment.For both the third quarter and first nine months of 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name. Home Health and Hospice assets were reduced by $6.0 million and $13.1 million, respectively, as of September 30, 2012 as a result of the impairment.

[2] (3) For the first nine months of 2012, interest expense and other, net included charges of $0.5 million relating to the write-off of deferred debt issuance costs associated with the revolving credit facility. See Note 2 for additional information.